comparemela.com

Latest Breaking News On - Akoya biosciences inc - Page 5 : comparemela.com

Akoya Biosciences Showcases Spatial Biology 2.0 Solutions at AACR Annual Meeting with Case Studies Demonstrating Unprecedented Speed and Scale

MARLBOROUGH, Mass., April 05, 2024 Akoya Biosciences, Inc., , The Spatial Biology Company®, today announced it will highlight case studies featuring its Spatial Biology 2.0 Solutions that.

Michigan
United-states
Brisbane
Queensland
Australia
San-diego
California
American
Akoya-biosciences
Priyam-shah
Fisher-view
Pascal-bamford

Akoya Biosciences, Inc. (NASDAQ:AKYA) Given Consensus Rating of "Moderate Buy" by Analysts

Akoya Biosciences, Inc. (NASDAQ:AKYA – Get Free Report) has been given an average recommendation of “Moderate Buy” by the seven research firms that are currently covering the company, MarketBeat reports. One equities research analyst has rated the stock with a hold rating and six have given a buy rating to the company. The average 12 […]

United-states
America
Akoya-biosciences
Asia-pacific
Brian-mckelligon
Barclays-plc
Nasdaq
Akoya-biosciences-inc
Citigroup-inc
Canaccord-genuity-group
Nisa-investment-advisors
Jpmorgan-chase-co

Akoya Biosciences (NASDAQ:AKYA) vs. Sartorius Stedim Biotech (OTCMKTS:SDMHF) Head to Head Comparison

Akoya Biosciences (NASDAQ:AKYA) vs. Sartorius Stedim Biotech (OTCMKTS:SDMHF) Head to Head Comparison
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

France
Massachusetts
United-states
Aubagne
Provence-alpes-côd-azur
America
Akoya-bioscience
Asia-pacific
Akoya-biosciences
Akoya-biosciences-inc
Sartorius-stedim-biotech

Akoya Biosciences, Inc. (NASDAQ:AKYA) CEO Brian Mckelligon Sells 7,500 Shares

Akoya Biosciences, Inc. (NASDAQ:AKYA) CEO Brian Mckelligon Sells 7,500 Shares
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United-states
America
Akoya-biosciences
Asia-pacific
Brian-mckelligon
Canaccord-genuity-group
Pura-vida-investments
Jpmorgan-chase-co
Kent-lake-capital
Akoya-biosciences-inc
Kennedy-capital-management
Securities-exchange-commission

Akoya Biosciences (NASDAQ:AKYA) Given New $10.00 Price Target at JPMorgan Chase & Co.

Akoya Biosciences (NASDAQ:AKYA – Free Report) had its price target trimmed by JPMorgan Chase & Co. from $12.00 to $10.00 in a report released on Wednesday morning, Benzinga reports. The firm currently has an overweight rating on the stock. Other equities research analysts have also issued reports about the company. Piper Sandler decreased their price […]

United-states
America
Asia-pacific
Brian-mckelligon
Akoya-biosciences
Piper-sandler
Akoya-biosciences-company-profile
Canaccord-genuity-group
Jpmorgan-chase-co
Citigroup-inc
Nisa-investment-advisors
Lazard-asset-management

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.